PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 2026Frontiers in Surgery0 citationsOpen Access

Case Report: Transrectal contrast-enhanced ultrasonography on preoperative evaluation of rectal neuroendocrine tumors: a 17-case preliminary study

JJJigang JingYWYan WuHZHua Zhuang

Key Points

  • Assess the feasibility of transrectal ultrasound in characterizing and evaluating rectal neuroendocrine neoplasms preoperatively.
  • Retrospective analysis of TRUS findings in 17 patients with confirmed rectal NENs between June 2020 and June 2025.
  • Comparison with ultrasound features of 31 cases of rectal cancer.
  • Evaluation included sonographic manifestations and pathological confirmations.
  • All 8 rectal NETs showed hypoechoic masses with clear borders; contrast-enhanced ultrasound showed inhomogeneous and homogeneous enhancement in 6 cases.
  • Among the 9 rectal NECs, 8 displayed irregular thickening and invasion of perirectal tissues; hypoechoic or heteroechoic lesions were noted with muscularis infiltration.
  • Overall concordance between ultrasonographic and surgical staging was 70.6% for all rectal NENs.

Abstract

Objective To evaluate the feasibility of transrectal ultrasound (TRUS) in the sonographic characterization and preoperative assessment of rectal neuroendocrine neoplasms (NENs). Methods Retrospective analysis was performed on the transrectal ultrasound manifestations and clinical data of 17 patients with pathologically and immunohistochemically confirmed rectal NENs 8 cases of rectal neuroendocrine tumors [NETs, G1/G2 and 9 cases of rectal neuroendocrine carcinomas NECs, G3] between June 2020 and June 2025. These TRUS findings were compared with the ultrasound features of 31 contemporaneous cases of middle- and lower-segment rectal cancer. Results All 8 rectal NETs (G1, G2) showed hypoechoic masses in the rectal mucosal and submucosal layers on TRUS, with clear borders in 8 cases, point-stripe blood flow signals in 7 cases, and round-shaped lymph nodes with a short diameter 5 mm in 3 cases; contrast-enhanced ultrasound (CEUS) was performed in 6 cases, showing inhomogeneous hyperenhancement in 2 cases and homogeneous isoenhancement in 4 cases. Among the 9 rectal NECs (G3), 8 presented with localized irregular thickening of the rectal wall, 7 invaded perirectal tissues or organs, all lesions were hypoechoic or heteroechoic with muscularis propria infiltration, and 4 cases had enlarged local lymph nodes. Compared with rectal cancer, the distribution of T stage (T1 vs. T2–4) differed significantly ( P = 0.016), whereas no significant differences were noted in gender, age, distance from the lower margin of the lesion to the intersphincteric sulcus, lesion length, lesion thickness, or N stage (all P 0.05). The overall concordance rate between ultrasonographic staging and surgical pathological staging was 70.6% (12/17) for all rectal NENs, with 87.5% (7/8) for NETs and 55.6% (5/9) for NECs. A limitation of this retrospective feasibility study is its relatively small sample size ( n = 17), which needs further verification in future multi-center large-sample studies. Conclusions Rectal NETs exhibit characteristic TRUS manifestations and require differentiation from polyps, adenocarcinomas, and inflammatory lesions. Transrectal contrast-enhanced ultrasonography (TR-CEUS), though not widely adopted, is feasible for the preoperative assessment of rectal NENs and may be valuable for follow-up after endoscopic resection to monitor recurrence.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jing et al. (2026) studied this question.

synapsesocial.com/papers/69f593f271405d493affec83https://doi.org/10.3389/fsurg.2026.1801458
Ask AI
Helpful
Bookmark
Share
View Full Paper